John A. Orwin
|
Director, PRESIDENT & CEO |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
11 Apr 2024 |
1 |
1
|
-
|
|
0
|
Series A Junior Preferred Stock |
Tito A. Serafini
|
Director |
Sale of securities on an exchange or to another person at price $ 0.07 per share. |
01 Apr 2024 |
20,788 |
43,636
(0%)
|
0%
|
0.1 |
1,455
|
Class A Common Stock |
Tito A. Serafini
|
Director |
Sale of securities on an exchange or to another person at price $ 0.37 per share. |
01 Sep 2023 |
8,393 |
64,424
(0%)
|
0%
|
0.4 |
3,144
|
Class A Common Stock |
John A. Orwin
|
Director, PRESIDENT & CEO |
Sale of securities on an exchange or to another person at price $ 0.37 per share. |
01 Sep 2023 |
22,951 |
77,541
(0%)
|
0%
|
0.4 |
8,597
|
Class A Common Stock |
Courtney J. Phillips
|
GENERAL COUNSEL & SECRETARY |
Sale of securities on an exchange or to another person at price $ 0.37 per share. |
01 Sep 2023 |
7,061 |
50,431
(0%)
|
0%
|
0.4 |
2,645
|
Class A Common Stock |
Stephen E. Gould
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 0.95 per share. |
02 Aug 2023 |
4,076 |
28,424
(0%)
|
0%
|
1.0 |
3,881
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 0.95 per share. |
02 Aug 2023 |
5,487 |
72,817
(0%)
|
0%
|
1.0 |
5,225
|
Class A Common Stock |
Courtney J. Phillips
|
General Counsel & Secretary |
Sale of securities on an exchange or to another person at price $ 0.95 per share. |
02 Aug 2023 |
4,076 |
57,492
(0%)
|
0%
|
1.0 |
3,881
|
Class A Common Stock |
Brian G. Atwood
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Franklin M. Berger
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Kristine M. Ball
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Stephen R. Brady
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Lindsey Rolfe
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
David L. Lacey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
William H. Robinson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Stacey Ma
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
175,000 |
175,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
43,750 |
78,304
(0%)
|
0%
|
|
0
|
Class A Common Stock |
John A. Orwin
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
435,000 |
435,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Courtney J. Phillips
|
General Counsel & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
130,000 |
130,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Courtney J. Phillips
|
General Counsel & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
32,500 |
61,568
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Stephen E. Gould
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
130,000 |
130,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Stephen E. Gould
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
32,500 |
32,500
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Philippe C. Bishop
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jan 2023 |
350,000 |
350,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 1.78 per share. |
02 Sep 2022 |
7,646 |
34,554
(0%)
|
0%
|
1.8 |
13,573
|
Class A Common Stock |
John A. Orwin
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 1.78 per share. |
02 Sep 2022 |
20,908 |
100,492
(0%)
|
0%
|
1.8 |
37,116
|
Class A Common Stock |
Courtney J. Phillips
|
General Counsel & Secretary |
Sale of securities on an exchange or to another person at price $ 1.78 per share. |
02 Sep 2022 |
6,432 |
29,068
(0%)
|
0%
|
1.8 |
11,418
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 2.02 per share. |
28 Jun 2022 |
15,000 |
228,875
(1%)
|
0%
|
2.0 |
30,266
|
Class A Common Stock |
Stephen E. Gould
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2022 |
200,000 |
200,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Jun 2022 |
50,145 |
0
|
-
|
|
-
|
Employee stock option (right to buy) |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2022 |
141,395 |
141,395
|
-
|
|
-
|
Employee stock option (right to buy) |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Jun 2022 |
88,000 |
0
|
-
|
|
-
|
Employee stock option (right to buy) |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2022 |
88,000 |
88,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Jun 2022 |
95,000 |
0
|
-
|
|
-
|
Employee stock option (right to buy) |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2022 |
95,000 |
95,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2022 |
50,145 |
50,145
|
-
|
|
-
|
Employee stock option (right to buy) |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Jun 2022 |
141,395 |
0
|
-
|
|
-
|
Employee stock option (right to buy) |
John A. Orwin
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2022 |
58,995 |
58,995
|
-
|
|
-
|
Employee stock option (right to buy) |
John A. Orwin
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2022 |
260,000 |
260,000
|
-
|
|
-
|
Employee stock option (right to buy) |
John A. Orwin
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Jun 2022 |
260,000 |
0
|
-
|
|
-
|
Employee stock option (right to buy) |
John A. Orwin
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2022 |
241,000 |
241,000
|
-
|
|
-
|
Employee stock option (right to buy) |
John A. Orwin
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Jun 2022 |
241,000 |
0
|
-
|
|
-
|
Employee stock option (right to buy) |
John A. Orwin
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2022 |
148,754 |
148,754
|
-
|
|
-
|
Employee stock option (right to buy) |
John A. Orwin
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Jun 2022 |
148,754 |
0
|
-
|
|
-
|
Employee stock option (right to buy) |
John A. Orwin
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Jun 2022 |
58,995 |
0
|
-
|
|
-
|
Employee stock option (right to buy) |
Courtney J. Phillips
|
General Counsel & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2022 |
65,000 |
65,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Courtney J. Phillips
|
General Counsel & Secretary |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Jun 2022 |
65,000 |
0
|
-
|
|
-
|
Employee stock option (right to buy) |
Courtney J. Phillips
|
General Counsel & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2022 |
80,000 |
80,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Courtney J. Phillips
|
General Counsel & Secretary |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Jun 2022 |
80,000 |
0
|
-
|
|
-
|
Employee stock option (right to buy) |
Courtney J. Phillips
|
General Counsel & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2022 |
45,000 |
45,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Courtney J. Phillips
|
General Counsel & Secretary |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Jun 2022 |
45,000 |
0
|
-
|
|
-
|
Employee stock option (right to buy) |
Courtney J. Phillips
|
General Counsel & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2022 |
91,666 |
91,666
|
-
|
|
-
|
Employee stock option (right to buy) |
Courtney J. Phillips
|
General Counsel & Secretary |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
13 Jun 2022 |
91,666 |
0
|
-
|
|
-
|
Employee stock option (right to buy) |
Brian G. Atwood
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2022 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Franklin M. Berger
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2022 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Kristine M. Ball
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2022 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Stephen R. Brady
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2022 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Lindsey Rolfe
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2022 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
David L. Lacey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2022 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
William H. Robinson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2022 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Stacey Ma
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2022 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 5.00 per share. |
04 Mar 2022 |
30,000 |
243,875
(1%)
|
0%
|
5 |
150,000
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Dec 2021 |
95,000 |
95,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
John A. Orwin
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Dec 2021 |
260,000 |
260,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Courtney J. Phillips
|
General Counsel & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Dec 2021 |
80,000 |
80,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
27 Sep 2021 |
50,000 |
303,875
(1%)
|
0%
|
|
0
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 6.58 per share. |
27 Sep 2021 |
30,000 |
273,875
(1%)
|
0%
|
6.6 |
197,541
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
27 Sep 2021 |
50,000 |
50,000
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Sep 2021 |
42,200 |
42,200
(0%)
|
0%
|
|
0
|
Class A Common Stock |
John A. Orwin
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Sep 2021 |
115,400 |
121,400
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Courtney J. Phillips
|
General Counsel & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Sep 2021 |
35,500 |
35,500
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Stacey Ma
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jul 2021 |
24,000 |
24,000
|
-
|
|
-
|
Stock Option (right to buy) |
Brian G. Atwood
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2021 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Franklin M. Berger
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2021 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Kristine M. Ball
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2021 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Lindsey Rolfe
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2021 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
David L. Lacey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2021 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
William H. Robinson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2021 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Mar 2021 |
2,916 |
9,013
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. |
17 Mar 2021 |
2,084 |
2,084
(0%)
|
0%
|
5.2 |
10,753
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 16.73 per share. |
17 Mar 2021 |
2,084 |
0
(0%)
|
0%
|
16.7 |
34,865
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. |
17 Mar 2021 |
2,916 |
2,916
(0%)
|
0%
|
4.6 |
13,297
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 16.73 per share. |
17 Mar 2021 |
2,916 |
0
(0%)
|
0%
|
16.7 |
48,785
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Mar 2021 |
2,084 |
32,915
|
-
|
|
-
|
Stock Option (right to buy) |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 16.89 per share. |
15 Mar 2021 |
5,000 |
368,948
(1%)
|
0%
|
16.9 |
84,450
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 18.84 per share. |
11 Mar 2021 |
1,500 |
353,875
(1%)
|
0%
|
18.8 |
28,260
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 18.22 per share. |
11 Mar 2021 |
8,500 |
355,375
(1%)
|
0%
|
18.2 |
154,870
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Feb 2021 |
5,000 |
34,999
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 18.95 per share. |
17 Feb 2021 |
5,000 |
0
(0%)
|
0%
|
19.0 |
94,752
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. |
17 Feb 2021 |
5,000 |
5,000
(0%)
|
0%
|
5.2 |
25,800
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 19.07 per share. |
16 Feb 2021 |
5,000 |
373,948
(1%)
|
0%
|
19.1 |
95,331
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 18.93 per share. |
11 Feb 2021 |
10,000 |
363,875
(1%)
|
0%
|
18.9 |
189,272
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2021 |
95,000 |
95,000
|
-
|
|
-
|
Employee stock option (right to buy) |
John A. Orwin
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2021 |
260,000 |
260,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2021 |
95,000 |
95,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Lisa Lynn Decker
|
Chief Business Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2021 |
80,000 |
80,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Courtney J. Phillips
|
General Counsel & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2021 |
80,000 |
80,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 15.21 per share. |
19 Jan 2021 |
5,000 |
0
(0%)
|
0%
|
15.2 |
76,045
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
19 Jan 2021 |
5,000 |
39,999
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. |
19 Jan 2021 |
5,000 |
5,000
(0%)
|
0%
|
5.2 |
25,800
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 15.05 per share. |
13 Jan 2021 |
2,741 |
381,207
(1%)
|
0%
|
15.0 |
41,239
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 15.06 per share. |
13 Jan 2021 |
2,259 |
378,948
(1%)
|
0%
|
15.1 |
34,011
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 15.02 per share. |
11 Jan 2021 |
10,000 |
373,875
(1%)
|
0%
|
15.0 |
150,192
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Dec 2020 |
5,000 |
6,929
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 16.61 per share. |
17 Dec 2020 |
5,000 |
0
(0%)
|
0%
|
16.6 |
83,051
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. |
17 Dec 2020 |
5,000 |
5,000
(0%)
|
0%
|
4.6 |
22,800
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 16.67 per share. |
14 Dec 2020 |
5,000 |
383,948
(1%)
|
0%
|
16.7 |
83,369
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 15.87 per share. |
11 Dec 2020 |
10,000 |
383,875
(1%)
|
0%
|
15.9 |
158,735
|
Class A Common Stock |
Brian G. Atwood
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
09 Dec 2020 |
12,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Brian G. Atwood
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
09 Dec 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Brian G. Atwood
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
09 Dec 2020 |
34,166 |
34,166
|
-
|
|
-
|
Stock Option (right to buy) |
Brian G. Atwood
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
09 Dec 2020 |
34,166 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Brian G. Atwood
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
09 Dec 2020 |
12,500 |
12,500
|
-
|
|
-
|
Stock Option (right to buy) |
Brian G. Atwood
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
09 Dec 2020 |
12,500 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 15.34 per share. |
27 Nov 2020 |
3,175 |
0
(0%)
|
0%
|
15.3 |
48,719
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
27 Nov 2020 |
3,175 |
11,929
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. |
27 Nov 2020 |
3,175 |
3,175
(0%)
|
0%
|
4.6 |
14,478
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 15.04 per share. |
17 Nov 2020 |
1,825 |
0
(0%)
|
0%
|
15.0 |
27,448
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Nov 2020 |
1,825 |
15,104
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. |
17 Nov 2020 |
1,825 |
1,825
(0%)
|
0%
|
4.6 |
8,322
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 15.12 per share. |
16 Nov 2020 |
8,847 |
393,875
(1%)
|
0%
|
15.1 |
133,784
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 15.00 per share. |
16 Nov 2020 |
5,000 |
388,948
(1%)
|
0%
|
15 |
75,000
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
11 Nov 2020 |
3,655 |
0
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
11 Nov 2020 |
3,655 |
3,655
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 15.10 per share. |
11 Nov 2020 |
1,153 |
399,067
(1%)
|
0%
|
15.1 |
17,407
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 15.10 per share. |
10 Nov 2020 |
4,500 |
0
(0%)
|
0%
|
15.1 |
67,963
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Nov 2020 |
4,500 |
16,929
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. |
10 Nov 2020 |
4,500 |
4,500
(0%)
|
0%
|
4.6 |
20,520
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. |
19 Oct 2020 |
500 |
500
(0%)
|
0%
|
4.6 |
2,280
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
19 Oct 2020 |
500 |
21,429
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 15.12 per share. |
19 Oct 2020 |
500 |
0
(0%)
|
0%
|
15.1 |
7,562
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 15.71 per share. |
13 Oct 2020 |
5,000 |
393,948
(1%)
|
0%
|
15.7 |
78,531
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 15.00 per share. |
12 Oct 2020 |
10,000 |
400,220
(1%)
|
0%
|
15 |
150,000
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 15.05 per share. |
06 Oct 2020 |
1,218 |
410,220
(1%)
|
0%
|
15.1 |
18,334
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 15.11 per share. |
18 Sep 2020 |
8,782 |
411,438
(1%)
|
0%
|
15.1 |
132,664
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 15.04 per share. |
18 Sep 2020 |
5,000 |
398,948
(1%)
|
0%
|
15.0 |
75,188
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 15.00 per share. |
14 Aug 2020 |
10,000 |
420,220
(1%)
|
0%
|
15 |
150,000
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 15.00 per share. |
14 Aug 2020 |
5,000 |
403,948
(1%)
|
0%
|
15 |
75,000
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 20.52 per share. |
13 Jul 2020 |
7,129 |
430,220
(1%)
|
0%
|
20.5 |
146,296
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 19.41 per share. |
13 Jul 2020 |
2,871 |
437,349
(1%)
|
0%
|
19.4 |
55,722
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 20.54 per share. |
13 Jul 2020 |
3,594 |
408,948
(1%)
|
0%
|
20.5 |
73,825
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 19.43 per share. |
13 Jul 2020 |
1,406 |
412,542
(1%)
|
0%
|
19.4 |
27,314
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 21.69 per share. |
01 Jul 2020 |
7,346 |
2,926
(0%)
|
0%
|
21.7 |
159,345
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jul 2020 |
10,272 |
21,929
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 22.17 per share. |
01 Jul 2020 |
2,926 |
0
(0%)
|
0%
|
22.2 |
64,879
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. |
01 Jul 2020 |
10,272 |
10,272
(0%)
|
0%
|
4.6 |
46,840
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 25.01 per share. |
25 Jun 2020 |
600 |
440,220
(1%)
|
0%
|
25.0 |
15,008
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 25.02 per share. |
25 Jun 2020 |
600 |
413,948
(1%)
|
0%
|
25.0 |
15,010
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 20.05 per share. |
19 Jun 2020 |
496 |
440,820
(2%)
|
0%
|
20.1 |
9,945
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 20.03 per share. |
19 Jun 2020 |
4,604 |
441,316
(2%)
|
0%
|
20.0 |
92,203
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 20.04 per share. |
19 Jun 2020 |
68 |
414,548
(1%)
|
0%
|
20.0 |
1,363
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 20.03 per share. |
19 Jun 2020 |
10,245 |
414,616
(1%)
|
0%
|
20.0 |
205,169
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 18.43 per share. |
15 Jun 2020 |
1,801 |
427,055
(1%)
|
0%
|
18.4 |
33,194
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 19.13 per share. |
15 Jun 2020 |
2,194 |
424,861
(1%)
|
0%
|
19.1 |
41,966
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 17.48 per share. |
15 Jun 2020 |
1,005 |
428,856
(1%)
|
0%
|
17.5 |
17,569
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 17.17 per share. |
11 Jun 2020 |
1,414 |
445,920
(2%)
|
0%
|
17.2 |
24,281
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 16.35 per share. |
11 Jun 2020 |
8,586 |
447,334
(2%)
|
0%
|
16.4 |
140,404
|
Class A Common Stock |
Brian G. Atwood
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Franklin M. Berger
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Kristine M. Ball
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Lindsey Rolfe
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
David L. Lacey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
William H. Robinson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 18.38 per share. |
01 Jun 2020 |
15,000 |
0
(0%)
|
0%
|
18.4 |
275,760
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jun 2020 |
15,000 |
32,201
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. |
01 Jun 2020 |
15,000 |
15,000
(0%)
|
0%
|
4.6 |
68,400
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 20.00 per share. |
28 May 2020 |
600 |
429,861
(1%)
|
0%
|
20.0 |
12,003
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 20.01 per share. |
27 May 2020 |
700 |
455,920
(2%)
|
0%
|
20.0 |
14,004
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 20.00 per share. |
27 May 2020 |
100 |
456,620
(2%)
|
0%
|
20 |
2,000
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 20.00 per share. |
26 May 2020 |
200 |
456,720
(2%)
|
0%
|
20 |
4,000
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 20.00 per share. |
26 May 2020 |
387 |
430,461
(1%)
|
0%
|
20 |
7,740
|
Class A Common Stock |
Kristine M. Ball
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 May 2020 |
24,000 |
24,000
|
-
|
|
-
|
Stock Option (right to buy) |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 20.00 per share. |
15 May 2020 |
1,700 |
456,920
(2%)
|
0%
|
20.0 |
34,004
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 20.00 per share. |
15 May 2020 |
2,200 |
458,620
(2%)
|
0%
|
20 |
44,000
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 20.00 per share. |
15 May 2020 |
1,600 |
430,848
(1%)
|
0%
|
20.0 |
32,003
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 20.00 per share. |
15 May 2020 |
2,100 |
432,448
(1%)
|
0%
|
20 |
42,000
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 17.32 per share. |
13 May 2020 |
200 |
434,548
(1%)
|
0%
|
17.3 |
3,463
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 16.80 per share. |
13 May 2020 |
4,800 |
434,748
(1%)
|
0%
|
16.8 |
80,642
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 18.22 per share. |
11 May 2020 |
6,288 |
460,820
(2%)
|
0%
|
18.2 |
114,560
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 17.64 per share. |
11 May 2020 |
3,712 |
467,108
(2%)
|
0%
|
17.6 |
65,465
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 18.00 per share. |
07 May 2020 |
5,000 |
0
(0%)
|
0%
|
18 |
90,000
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 May 2020 |
5,000 |
47,201
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. |
07 May 2020 |
5,000 |
5,000
(0%)
|
0%
|
4.6 |
22,800
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. |
01 May 2020 |
10,000 |
10,000
(0%)
|
0%
|
4.6 |
45,600
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 May 2020 |
10,000 |
52,201
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 15.03 per share. |
01 May 2020 |
10,000 |
0
(0%)
|
0%
|
15.0 |
150,276
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 17.01 per share. |
16 Apr 2020 |
2,919 |
471,620
(2%)
|
0%
|
17.0 |
49,643
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 17.74 per share. |
16 Apr 2020 |
800 |
470,820
(2%)
|
0%
|
17.7 |
14,193
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 15.75 per share. |
16 Apr 2020 |
6,281 |
474,539
(2%)
|
0%
|
15.8 |
98,926
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 16.94 per share. |
16 Apr 2020 |
1,300 |
440,048
(1%)
|
0%
|
16.9 |
22,026
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 17.72 per share. |
16 Apr 2020 |
500 |
439,548
(1%)
|
0%
|
17.7 |
8,861
|
Class A Common Stock |
William H. Robinson
|
Director |
Sale of securities on an exchange or to another person at price $ 15.74 per share. |
16 Apr 2020 |
3,200 |
441,348
(2%)
|
0%
|
15.7 |
50,384
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 18.00 per share. |
14 Apr 2020 |
5,000 |
0
(0%)
|
0%
|
18 |
90,000
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Apr 2020 |
5,000 |
62,201
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. |
14 Apr 2020 |
5,000 |
5,000
(0%)
|
0%
|
4.6 |
22,800
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 15.01 per share. |
08 Apr 2020 |
8,000 |
0
(0%)
|
0%
|
15.0 |
120,101
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Apr 2020 |
8,000 |
67,201
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. |
08 Apr 2020 |
8,000 |
8,000
(0%)
|
0%
|
4.6 |
36,480
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 15.21 per share. |
01 Apr 2020 |
2,000 |
0
(0%)
|
0%
|
15.2 |
30,422
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2020 |
2,000 |
75,201
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. |
01 Apr 2020 |
2,000 |
2,000
(0%)
|
0%
|
4.6 |
9,120
|
Class A Common Stock |
John A. Orwin
|
Director, President & CEO |
Purchase of securities on an exchange or from another person at price $ 12.79 per share. |
17 Mar 2020 |
6,000 |
6,000
(0%)
|
0%
|
12.8 |
76,740
|
Class A Common Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Feb 2020 |
88,000 |
88,000
|
-
|
|
-
|
Employee stock option (right to buy) |
John A. Orwin
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Feb 2020 |
241,000 |
241,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Feb 2020 |
88,000 |
88,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Lisa Lynn Decker
|
Chief Business Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Feb 2020 |
48,000 |
48,000
|
-
|
|
-
|
Employee stock option (right to buy) |
Guy Cavet
|
Chief Technical Officer |
Sale of securities on an exchange or to another person at price $ 20.00 per share. |
27 Jan 2020 |
10,000 |
92,758
(0%)
|
0%
|
20 |
200,000
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 18.47 per share. |
24 Jan 2020 |
5,000 |
0
(0%)
|
0%
|
18.5 |
92,346
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
24 Jan 2020 |
5,000 |
107,201
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. |
24 Jan 2020 |
5,000 |
5,000
(0%)
|
0%
|
4.6 |
22,800
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 14.83 per share. |
17 Jan 2020 |
9,092 |
9,092
(0%)
|
0%
|
14.8 |
134,852
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Jan 2020 |
10,000 |
112,201
|
-
|
|
-
|
Stock Option (right to buy) |
Norman Michael Greenberg
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 15.57 per share. |
17 Jan 2020 |
908 |
0
(0%)
|
0%
|
15.6 |
14,140
|
Class A Common Stock |
Norman Michael Greenberg
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. |
17 Jan 2020 |
10,000 |
10,000
(0%)
|
0%
|
4.6 |
45,600
|
Class A Common Stock |
Guy Cavet
|
Chief Technical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. |
17 Jan 2020 |
1,919 |
109,677
(0%)
|
0%
|
5.2 |
9,902
|
Class A Common Stock |
Guy Cavet
|
Chief Technical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Jan 2020 |
1,919 |
48,080
|
-
|
|
-
|
Stock Option (right to buy) |
Guy Cavet
|
Chief Technical Officer |
Sale of securities on an exchange or to another person at price $ 15.59 per share. |
17 Jan 2020 |
524 |
102,758
(0%)
|
0%
|
15.6 |
8,169
|
Class A Common Stock |
Guy Cavet
|
Chief Technical Officer |
Sale of securities on an exchange or to another person at price $ 14.84 per share. |
17 Jan 2020 |
6,395 |
103,282
(0%)
|
0%
|
14.8 |
94,896
|
Class A Common Stock |
Lindsey Rolfe
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Aug 2019 |
24,000 |
24,000
|
-
|
|
-
|
Stock Option (right to buy) |
Phillips Courtney
|
General Counsel & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jul 2019 |
45,000 |
45,000
|
-
|
|
-
|
Stock Option (right to buy) |
Brian G. Atwood
|
None |
|
24 Jun 2019 |
4,504 |
0
|
-
|
|
-
|
Series A Preferred Stock |
Brian G. Atwood
|
None |
|
24 Jun 2019 |
4,287 |
0
|
-
|
|
-
|
Series B Preferred Stock |
Brian G. Atwood
|
None |
|
24 Jun 2019 |
8,791 |
49,654
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Franklin M. Berger
|
None |
|
24 Jun 2019 |
75,315 |
97,808
(0%)
|
0%
|
|
0
|
Class A Common Stock |
Franklin M. Berger
|
None |
|
24 Jun 2019 |
13,164 |
0
|
-
|
|
-
|
Series C1 Preferred Stock |
Franklin M. Berger
|
None |
|
24 Jun 2019 |
26,115 |
0
|
-
|
|
-
|
Series B Preferred Stock |
Franklin M. Berger
|
None |
|
24 Jun 2019 |
36,036 |
0
|
-
|
|
-
|
Series A Preferred Stock |
Lawrence J. Steinman
|
None |
|
24 Jun 2019 |
8,405 |
258,405
(1%)
|
0%
|
|
0
|
Class A Common Stock |
Lawrence J. Steinman
|
None |
|
24 Jun 2019 |
8,405 |
0
|
-
|
|
-
|
Series A Preferred Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
|
24 Jun 2019 |
6,431 |
0
|
-
|
|
-
|
Series B Preferred Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
|
24 Jun 2019 |
5,703 |
0
|
-
|
|
-
|
Series A Preferred Stock |
Tito A. Serafini
|
Director, Chief Strategy Officer |
|
24 Jun 2019 |
12,134 |
480,820
(2%)
|
0%
|
|
0
|
Class A Common Stock |
William H. Robinson
|
None |
|
24 Jun 2019 |
5,703 |
0
|
-
|
|
-
|
Series A Preferred Stock |
William H. Robinson
|
None |
|
24 Jun 2019 |
4,287 |
0
|
-
|
|
-
|
Series B Preferred Stock |
William H. Robinson
|
None |
|
24 Jun 2019 |
9,990 |
9,990
(0%)
|
0%
|
|
0
|
Class A Common Stock |